Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A16927 | 28089433 | Surg Obes Relat Dis | Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity. | 2016 | Details |
A16928 | 28089429 | Rev Gastroenterol Mex | Diagnosis and quantification of fibrosis, steatosis, and hepatic siderosis through multiparametric magnetic resonance imaging. | 2017 | Details |
A16930 | 28088781 | Oncotarget | MiR-30c-5p ameliorates hepatic steatosis in leptin receptor-deficient (db/db) mice via down-regulating FASN. | 2017 | Details |
A16931 | 28088462 | Gastroenterology | Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones. | 2017 | Details |
A16932 | 28088461 | Gastroenterology | Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation. | 2017 | Details |
A16933 | 28086768 | BMC Complement Altern Med | Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. | 2017 | Details |
A16935 | 28084795 | Appl Physiol Nutr Metab | Moderate physical activity promotes basal hepatic autophagy in diet-induced obese mice. | 2016 | Details |
A16936 | 28084058 | J Diabetes Investig | Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice. | 2017 | Details |
A16937 | 28083083 | World J Hepatol | Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease. | 2016 | Details |
A16938 | 28083033 | Pak J Med Sci | Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease. | 2020 | Details |
A16939 | 28082803 | World J Gastroenterol | Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. | 2016 | Details |
A16940 | 28082742 | Exp Mol Med | Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes. | 2017 | Details |
A16941 | 28082024 | Clin Chim Acta | Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: Interrelationship with age. | 2017 | Details |
A16942 | 28081780 | Metabolism | Association between vascular inflammation and non-alcoholic fatty liver disease: Analysis by 18F-fluorodeoxyglucose positron emission tomography. | 2016 | Details |
A16943 | 28081779 | Metabolism | Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study. | 2016 | Details |
A16944 | 28081181 | PLoS One | Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation. | 2017 | Details |
A16945 | 28079806 | Medicine (Baltimore) | The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm. | 2017 | Details |
A16946 | 28079667 | Eur J Gastroenterol Hepatol | Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis. | 2017 | Details |
A16947 | 28078997 | Curr Med Chem | Lipoprotein (a) and Cardiovascular Risk: The Show Must go on. | 2017 | Details |
A16948 | 28077863 | Int J Obes (Lond) | What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications? | 2017 | Details |
A16949 | 28077733 | J Nutr | Identification of Potential Plasma Biomarkers for Nonalcoholic Fatty Liver Disease by Integrating Transcriptomics and Proteomics in Laying Hens. | 2017 | Details |
A16950 | 28077318 | Exp Mol Pathol | Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. | 2017 | Details |
A16951 | 28077274 | Biochimie | The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. | 2017 | Details |
A16952 | 28076482 | Arq Bras Cir Dig | CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY. | 2017 | Details |
A16953 | 28076416 | PLoS One | The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis. | 2017 | Details |
A16954 | 28075394 | Nutrients | Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B. | 2017 | Details |
A16955 | 28075092 | Am Fam Physician | Diabetes Mellitus: Management of Gastrointestinal Complications. | 2016 | Details |
A16960 | 28073424 | Zhonghua Gan Zang Bing Za Zhi | [NACHT-LRR-PYD-containing proteins 3 inflammasome and nonalcoholic fatty liver disease]. | 2016 | Details |
A16961 | 28073422 | Zhonghua Gan Zang Bing Za Zhi | [Research advances in the association between deacetylase Sirtuin3 and liver diseases]. | 2016 | Details |
A16962 | 28073414 | Zhonghua Gan Zang Bing Za Zhi | [Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease]. | 2016 | Details |
A16963 | 28073183 | Hepatology | A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis. | 2017 | Details |
A16964 | 28073164 | Hepatology | Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in mice. | 2017 | Details |
A16967 | 28070199 | Hepat Mon | Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience. | 2016 | Details |
A16968 | 28070183 | Gastroenterol Res Pract | Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver Disease. | 2016 | Details |
A16969 | 28070145 | Mediators Inflamm | Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis. | 2016 | Details |
A16971 | 28069746 | Postgrad Med J | Non-alcoholic fatty pancreas disease. | 2017 | Details |
A16972 | 28068223 | Cell Metab | Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. | 2016 | Details |
A16973 | 28068221 | Cell Metab | Devilish Effects of Taz in Nonalcoholic Steatohepatitis. | 2016 | Details |
A16974 | 28067690 | J Pediatr Hematol Oncol | Iron Overload in the Liver of 2 Children: Nonalcoholic Steatohepatitis and Juvenile Hemochromatosis. | 2017 | Details |
A16975 | 28067590 | Biosci Biotechnol Biochem | BCL11B gene heterozygosity causes weight loss accompanied by increased energy consumption, but not defective adipogenesis, in mice. | 2017 | Details |
A16976 | 28067231 | Sci Rep | Multiomics reveal non-alcoholic fatty liver disease in rats following chronic exposure to an ultra-low dose of Roundup herbicide. | 2017 | Details |
A16977 | 28067223 | Nat Commun | The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner. | 2017 | Details |
A16978 | 28067024 | Mol Nutr Food Res | Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function. | 2017 | Details |
A16979 | 28065744 | Clin Res Hepatol Gastroenterol | Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2017 | Details |
A16980 | 28064372 | Obes Surg | Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction. | 2017 | Details |
A16981 | 28064013 | J Nutr Biochem | Changes in liver proteins of rats fed standard and high-fat and sucrose diets induced by fish omega-3 PUFAs and their combination with grape polyphenols according to quantitative proteomics. | 2016 | Details |
A16982 | 28064001 | Biochim Biophys Acta Mol Cell Res | Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases. | 2017 | Details |
A16983 | 28063601 | Clin Radiol | Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease. | 2017 | Details |
A16984 | 28063505 | Nutrition | Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials. | 2016 | Details |
A16985 | 28063221 | J Cell Physiol | Novel circulating biomarkers for non-alcoholic fatty liver disease: A systematic review. | 2017 | Details |
A16986 | 28063004 | Mol Cell Biochem | Tubulin alpha 8 is expressed in hepatic stellate cells and is induced in transformed hepatocytes. | 2017 | Details |
A16987 | 28062946 | J Gastroenterol | Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
A16988 | 28062870 | Rev Gastroenterol Peru | [Metabolic parameters in patients with steatosis non alcoholic liver and controlled diabetes type 2 versus uncontrolled diabetes type 2]. | 2017 | Details |
A16989 | 28062263 | Magn Reson Imaging | The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis mice. | 2017 | Details |
A16991 | 28058397 | North Clin Istanb | The prevalence of non-alcoholic fatty liver disease in healthy young persons. | 2016 | Details |
A16992 | 28058253 | Can J Gastroenterol Hepatol | More Frequent Clinic Visits Are Associated with Improved Outcomes for Children with NAFLD. | 2016 | Details |
A16993 | 28058076 | Gastroenterology Res | Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature. | 2016 | Details |
A16994 | 28056552 | Exp Biol Med (Maywood) | Soy protein isolate inhibits hepatic tumor promotion in mice fed a high-fat liquid diet. | 2017 | Details |
A16995 | 28056321 | Zhonghua Nei Ke Za Zhi | [The significance of 8-hydroxy-deoxyguanosine acid in the diagnosis of nonalcoholic steatohepatitis]. | 2017 | Details |
A16996 | 28053786 | Int J Hepatol | Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease. | 2016 | Details |
A16997 | 28053681 | Prz Gastroenterol | Relationship between psoriasis and non-alcoholic fatty liver disease. | 2016 | Details |
A16998 | 28053680 | Prz Gastroenterol | Reduction of sitting time has a positive effect on the decrease of insulin resistance in patients with non-alcoholic fatty liver disease. | 2016 | Details |
A16999 | 28053651 | Comput Math Methods Med | The Reliability of Classification of Terminal Nodes in GUIDE Decision Tree to Predict the Nonalcoholic Fatty Liver Disease. | 2016 | Details |
A17000 | 28053338 | Nat Rev Gastroenterol Hepatol | Autophagy in the liver: functions in health and disease. | 2017 | Details |
A17001 | 28053201 | Br J Sports Med | Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review. | 2017 | Details |
A17002 | 28052636 | Liver Int | Non-pharmacological interventions in non-alcoholic fatty liver disease patients. | 2017 | Details |
A17003 | 28052629 | Liver Int | Pathology of non-alcoholic fatty liver disease. | 2017 | Details |
A17004 | 28052626 | Liver Int | Therapies in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
A17005 | 28052624 | Liver Int | The epidemiology of non-alcoholic fatty liver disease. | 2017 | Details |
A17006 | 28052618 | Liver Int | The future of liver transplantation for viral hepatitis. | 2017 | Details |
A17007 | 28052604 | Am J Transplant | OPTN/SRTR 2015 Annual Data Report: Liver. | 2017 | Details |
A17008 | 28051796 | Ann Hepatol |  Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis. | 2017 | Details |
A17009 | 28051792 | Ann Hepatol | Management strategies for liver fibrosis. | 2017 | Details |
A17010 | 28051263 | Eur Rev Med Pharmacol Sci | Psychological factors associated with NAFLD/NASH: a systematic review. | 2016 | Details |
A17011 | 28051126 | Sci Rep | Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis. | 2017 | Details |
A17012 | 28050580 | Data Brief | Microarray data and pathway analyses for primary human activated hepatic stellate cells compared to HepG2 human hepatoma cells. | 2016 | Details |
A17013 | 28050048 | Am J Gastroenterol | Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI… Is It in the Genes? | 2017 | Details |
A17014 | 28049265 | Asia Pac J Clin Nutr | Increased dietary zinc and vitamin B-2 is associated with increased alanine aminotransferase in Taiwanese adolescents. | 2017 | Details |
A17015 | 28044208 | J Gastroenterol | Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis. | 2017 | Details |
A17018 | 28042486 | Int J Hepatol | A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice. | 2016 | Details |
A17019 | 28040498 | Dig Liver Dis | CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation study. | 2016 | Details |
A17020 | 28040302 | Clin Nutr | Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials. | 2016 | Details |
A17021 | 28040242 | Ultrasound Med Biol | Acoustic Impedance Analysis with High-Frequency Ultrasound for Identification of Fatty Acid Species in the Liver. | 2016 | Details |
A17022 | 28039158 | Am J Physiol Gastrointest Liver Physiol | Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis. | 2016 | Details |
A17023 | 28039099 | J Hepatol | Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. | 2016 | Details |
A17024 | 28038998 | Toxicol Appl Pharmacol | Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice. | 2016 | Details |
A17026 | 33442082 | J ASEAN Fed Endocr Soc | Diabetes Mellitus and Prediabetes in Patients with Hepatocellular Carcinoma in a Tertiary Philippine Hospital. | 2017 | Details |
A17027 | 31509653 | Klin Lab Diagn | [The cognitive biological function, difference in etiology and generality of pathogenesis of metabolic pandemics. The metabolism regulation in carnivorous and herbivorous animals under effect of environment factors.] | 2017 | Details |
A17028 | 30802390 | Klin Lab Diagn | [The phylogenetic theory of general pathology. The development of seven biological functions, seven specific ones and etiological factors of metabolic epidemics, millions years' common pathogenesis and basics of prevention.] | 2019 | Details |
A17029 | 30276302 | Brain Circ | Nonalcoholic fatty liver disease as an independent risk factor for carotid atherosclerosis. | 2017 | Details |
A17030 | 30123836 | Hepatoma Res | Roles of p53 in extrinsic factor-induced liver carcinogenesis. | 2017 | Details |
A17031 | 29984130 | Curr Hepatol Rep | Natural History of NAFLD/NASH. | 2017 | Details |
A17032 | 29911800 | Yao Xue Xue Bao | [Protective effect and underlying mechanism of cordycepin on non-alcoholic fatty liver in ob/ob mice]. | 2017 | Details |
A17033 | 29716685 | Acta Medica (Hradec Kralove) | SGLT-2 Inhibitors: Are They a Promising Treatment Option in T2DM Patients with NAFLD? | 2018 | Details |
A17034 | 29511485 | Gastroenterol Hepatol Bed Bench | Protein interaction mapping interpretation of none alcoholic fatty liver disease model of rats after fat diet feeding. | 2017 | Details |
A17035 | 29511467 | Gastroenterol Hepatol Bed Bench | Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patients. | 2017 | Details |
A17036 | 29511464 | Gastroenterol Hepatol Bed Bench | Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |
A17037 | 28038359 | J Nutr Biochem | Green tea extract treatment reduces NFκB activation in mice with diet-induced nonalcoholic steatohepatitis by lowering TNFR1 and TLR4 expression and ligand availability. | 2016 | Details |
A17038 | 28036028 | Nutrients | Application of an In Vivo Hepatic Triacylglycerol Production Method in the Setting of a High-Fat Diet in Mice. | 2016 | Details |
A17039 | 28035771 | Hepatology | Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study. | 2016 | Details |